OncoCyte
Oncocyte Notified That It Lost, Regained Nasdaq Compliance
The issue arose with the death in April of a board member, who was also a member of Oncocyte's audit committee, and was resolved with a new appointment this month.
Earnings Roundup: Renalytix, DermTech, Oncocyte, Aspira Women's Health, Exagen, More
Renalytix, DermTech, Oncocyte, Aspira Women's Health, and others reported their first quarter earnings this week.
Oncocyte, Bio-Rad Partner to Globally Launch Transplant Test
The test is expected to launch in Q2 2024 to select academic transplant centers in the US and EU and more broadly in the second half of the year.
CMS Clarifies Billing Article Revisions for Organ Transplant Rejection Testing
A statement from CMS clarifies that physician-ordered transplant rejection tests remain available when medically necessary.
In Brief This Week: NIH; Danaher; OpGen; Oncocyte; More
News items for the week of Dec. 4, 2023.
Jul 24, 2023
Oncocyte Initiates 1-for-20 Reverse Stock Split
Apr 13, 2023
Oncocyte Lays off 20 Percent of Workforce
Apr 14, 2022